Advertisement

Topics

Tanabe Seiyaku Company Limited Company Profile

12:38 EDT 20th September 2017 | BioPortfolio

Drug Discovery Cardiovascular Therapeutics

Location

26 Sanban-cho Chiyoda-ku
Tokyo
Tokyo
102
Japan

Contact

Phone: 81 3 3230 6768
Fax: 81 3 3230 6675


News Articles [377 Associated News Articles listed on BioPortfolio]

Mitsubishi Tanabe to buy Israel's NeuroDerm for $1.1 bn

Japan's Mitsubishi Tanabe Pharma announced Monday a billion-dollar deal to buy an Israeli company that specialises in developing treatments for Parkinson's disease.

Mitsubishi Tanabe Buys NeuroDerm for $1.1 Bilion

Japanese drugmaker Mitsubishi Tanabe Pharma has agreed to acquire Israel’s NeuroDerm for around $1.1 billion in cash.

NeuroDerm purchased by Mitsubishi Tanabe for $1.1B

Parkinson's disease drug firm NeuroDerm has been acquired by Mitsubishi Tanabe Pharma for $1.1 billion.  -More- 

Mitsubishi Tanabe Pharma Corporation Strategy, SWOT and Corporate Finance Report [Report Updated: 03082017] Prices from USD $175

Mitsubishi Tanabe Pharma Corporation Strategy, SWOT and Corporate Finance ReportSummaryMitsubishi Tanabe Pharma Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive ...

Mitsubishi Tanabe to acquire NeuroDerm for $1.1bn

Japan-based Mitsubishi Tanabe Pharma (MTPC) has agreed to acquire Israeli drug manufacturer NeuroDerm in an all-cash deal worth $1.1bn.

Mitsubishi Tanabe Pharma to buy NeuroDerm for $1.1bn

Japan’s Mitsubishi Tanabe Pharma (MTPC) has entered a new definitive agreement to acquire all of the outstanding shares of Israel-based pharmaceutical company NeuroDerm for $1.1bn in cash.

Mitsubishi Tanabe Pharma acquires NeuroDerm for $1bn

Mitsubishi Tanabe Pharma Corp. is acquiring public Israeli biotech NeuroDerm Ltd. (reformulates CNS disorder therapeutics as drug/device combinations for infusion) for $39 in cash per share (a 28% pre...

Mitsubishi Tanabe to pay $1.1bn for Parkinson's drug formulator Neuroderm

Mitsubishi Tanabe Pharma has agreed to pay $1.1bn (€943m) to acquire Parkinson’s disease focused formulation and drug-device developer Neuroderm Ltd.

Clinical Trials [67 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery

During laparoscopy, administration of cold and dry carbon dioxide (CO2) leads to hypothermia. Different types of gas conditioning have been studied in order to prevent this specific hypoth...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Companies [1453 Associated Companies listed on BioPortfolio]

Tanabe Seiyaku Co., Ltd

Tanabe Seiyaku Co., Ltd. ("the Company"), in consideration of the importance of personal information protection and in order to appropriately protect personal information, strictly observes Japan's Ac...

Tanabe Research Laboratories U.S.A., Inc

Tanabe Research Laboratories U.S.A., Inc. (TRL), is a wholly owned subsidiary of Tanabe Seiyaku Co., Ltd., headquartered in Osaka, Japan. TRL has a research group of approximately 32 employees which i...

Tanabe Seiyaku Company Limited

Drug Discovery Cardiovascular Therapeutics

Tanabe Research Labs USA

Tanabe Research Laboratories U.S.A., Inc. (TRL), is a wholly owned subsidiary of Tanabe Seiyaku Co., Ltd., headquartered in Osaka, Japan. The mission of TRL is to discover, optimize and develop innova...

TEIKOKU SEIYAKU CO.,LTD

1848 Shozo Akazawa, the fifth head of the Akazawa family, obtains a certificate granting him permission from the government to deal in medicines, and goes into business. Teikoku Seiyaku, our stance ha...

More Information about "Tanabe Seiyaku Company Limited" on BioPortfolio

We have published hundreds of Tanabe Seiyaku Company Limited news stories on BioPortfolio along with dozens of Tanabe Seiyaku Company Limited Clinical Trials and PubMed Articles about Tanabe Seiyaku Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tanabe Seiyaku Company Limited Companies in our database. You can also find out about relevant Tanabe Seiyaku Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record